5588
D. Takács et al. / Tetrahedron Letters 53 (2012) 5585–5588
7. Motohashi, N.; Kawase, M.; Saito, S.; Sakagami, H. Curr. Drug Targets 2000, 1,
1. HCl (10%),
S
237.
RT, 70 min
2 steps
1,4-dioxane
2. HCl/Et2O
HCl
8. Madrid, P. B.; Polgar, W. E.; Tolla, L.; Tanga, M. J. Bioorg. Med. Chem. Lett. 2007,
17, 3014.
3d
1
NH2
N
H
9. Dixit, R.; Gautam, N.; Gautam, D. C. Jordan J. Chem. 2008, 3, 357.
10. Gautham, V.; Sharma, M.; Samarth, R. M.; Gautham, N.; Kumar, A.; Sharma, I.
K.; Gautham, D. C. Phosphorus Sulfur Silicon 2007, 182, 1381.
11. Charpentier, P. U.S. Patent 2645,640, 1953; Chem. Abstr. 1955, 49, 16278.
12. Craig, P.; Nodiff, E.; Lafferty, E. J.; Ullyot, G. J. Org. Chem. 1957, 22, 709.
13. For Boc-protection of a related compounds, see: Okamoto, T.; Karutsu, M.;
Kozaki, M.; Hirotsu, K.; Ichimira, A.; Matsushita, T.; Okada, K. Org. Lett. 2004, 6,
3493.
12
Scheme 4. Conversion of 2-chlorophenothiazine (1) into phenothiazine-2-amine
hydrochloride salt (12).
14. (a) Dai, Q.; Gao, W.; Liu, D.; Kapes, L. M.; Zhang, X. J. Org. Chem. 2006, 71, 3928;
(b) Kotecki, B. J.; Fernando, D. P.; Haight, A. R.; Lukin, K. A. Org. Lett. 2009, 11,
947; (c) Guram, A. S.; Rennels, R. A.; Buchwald, S. L. Angew. Chem., Int. Ed. 1995,
34, 1348.
and related compounds provides an easy and general access to
phenothiazine-2-amines and amides.
15. General procedure for the preparation of Boc-protected phenothiazine-2-
amines and 2-amides 3a–e: A round–bottomed flask was charged with Pd-
catalyst (5.0–7.5 mol %), XPhos (10–15 mol %), tert-butyl-10H-phenothiazine-
10-carboxylate (2, 1 equiv), amine/ amide (2 equiv), base (2 equiv), and dry
toluene (5 ml). The flask was flushed with argon for 5 min. The resulting
mixture was heated at reflux with magnetic stirring for 0.5–4 h. After cooling
to room temperature the mixture was concentrated and the residue purified by
flash column chromatography on silica gel using the appropriate eluent.
16. Self, J. L.; Khanapure, S. P.; Biehl, E. R. Heterocycles 1991, 32, 311.
17. Nagy, I.; Riedl, Zs.; Hajós, Gy.; Messmer, A.; Gyémánt, N.; Molnár, J. Arkivoc
2004, vii, 177.
18. Gritsenko, A. N.; Zhuravlev, S. V.; Panova, E. D.; Skorodumov, V. A. Khim.
Geterocycl. Soedin. 1967, 3, 668.
19. Gritsenko, A. N.; Zhuravlev, S. V. J. Gen. Chem. USSR (Eng. Transl.) 1963, 33,
3697–3699, 3628–3630.
20. Richards, L. E.; Pieniaszek, H. J.; Schatzmiller, S.; Page, G. O.; Blom, K. F.; Read, J.
M.; Davidson, A. F.; Confalone, P. N. Xenobiotica 1997, 27, 217.
Acknowledgment
Financial support from the Hungarian Scientific Research Fund
OTKA-NK 77784 is gratefully acknowledged.
Supplementary data
Supplementary data associated with this article can be found, in
the online (detailed experimentals for all compounds including 1H
and 13C NMR spectral assignments, and elemental analysis) ver-
References and notes
21. To
a solution of tert-butyl-2-formamido-10H-phenothiazine-10-carboxylate
(3d, 0.1 g, 0.29 mmol) in 1,4-dioxane (2.7 ml), 10% aqueous HCl (2 ml) was
added dropwise at room temperature over 20 min. After completion of the
reaction (70 min, approximately) the mixture was poured onto ice water, made
alkaline with 10% aqueous Na2CO3 and extracted with CH2Cl2 (3 ꢀ 5 ml). The
combined organic phase was dried over anhydrous Na2SO4, filtered and
concentrated. The residue was purified by column chromatography on silica
gel (gradient CHCl3: MeOH = 10:1). The product was dissolved in Et2O, and a
few drops of MeOH then 4 N HCl/ Et2O were added at 0 °C. The product 12
(hydrochloride salt) was isolated by filtration as green-grey crystals (40 mg,
58%), mp 238–242 °C.
1. Molnar, J.; Sakagami, H.; Motohashi, N. Anticancer Res. 1993, 13, 1019.
2. Grácio, M. A.; Grácio, A. J. dos S.; Viveiros, M.; Amaral, L. Int. J. Antimicrobial.
Agents 2003, 22, 347.
3. Okumuraa, H.; Nakazawa, J.; Tsuganezawa, K.; Usui, T.; Osada, H.; Matsumoto,
T.; Tanaka, A.; Yokoyama, H. Toxicol. Lett. 2006, 166, 44.
4. Zhang, Y.; Ballard, C. E.; Zheng, S.-L.; Gao, X.; Ko, K.-C.; Yang, H.; Brandt, G.; Lou,
X.; Tai, P. C.; Luc, C.-D.; Wanga, B. Bioorg. Med. Chem. Lett. 2007, 17, 707.
5. Amaral, L.; Viveiros, M.; Molnár, J. In Vivo 2004, 725.
6. Wesołowska, O.; Molnár, J.; Ocsovszki, I.; Michalak, K. In Vivo 2009, 23, 943.